It has been proposed that hypoxic and glycolytic tumour cells distant from functional blood vessels use MCT4 to export lactic acid, which is then absorbed by the peripheral oxidative tumour cells through MCT1 [42]. Here, SLC16A1 is linked to neoplasm.